Growth hormone/insulin-like growth factors and hematopoiesis

NeuroImmune Biology

Volumn 2, Issue C, 2002, Pages 177-186

  Moghaddas, Robert ^a   Rapaport, Robert ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12344253420     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(02)80016-3     Document Type: Article

References (56)

1. Leroith D., Bondy C., Yakar S., Liu J.L., and Butler A. Somatomedin hypothesis 2001. Endo Review 22 1 (2001) 53-74
2. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocrine Reviews 20 6 (1999) 761-787
3. Mirza A.M., Ezzat S., and Axelrad A.A. IGFBP-I is elevated in patients with polycythemia vera and stimulates erythroid burst foramtion in vitro. Blood 89 (1997) 1862-1866
4. Merchav S. The hematopoietic effects of growth hormone and IGF-I. J Ped Endocrinol Metab 11 6 (1998) 677-685
5. LeRoith D., Werner H., Beitner Johnson D., and Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Reviews 16 (1995) 143-163
6. Lamothe B., Baudry A., Christofferson C.T., De Meyts P., Jami J., Bucchini D., and Joshi R.L. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors. Federation of European biochemical societies letters 426 (1998) 381-385
7. Wu H., Klingmuller U., Besmer P., and Lodish H.F. Interaction of the erythropoietin and stemcell factor receptors. Nature 377 (1995) 242-246
8. Sawada K., Krantz S.B., Dessypris E.N., Koury S.T., and Sawyer S.T. Human colony forming units erythroid don't require accessory cells, but do require direct interaction with insulin like growth factor I and/or insulin for erythroid development. Journal of Clinical Investigation 83 (1989) 1701-1709
9. Krantz S.B. Erythropoietin. Blood 77 (1991) 419-434
10. Gordon A.S. Endocrine influences upon the formed elements of blood and blood forming organs. Recent Progress in Hormone Research 10 (1954) 339-394
11. Golde D.W., Bersch N., and Hao L.I. GH species specific stimulation of erythropoiesis in vitro. Science 196 (1977) 1112-1113
12. Merchay S., Tatarsky I., and Hochberg Z. Enhancement of erythropoiesis in vitro by human GH is mediated by IGF-1. Br J Haematology 70 (1988) 267-271
13. Merchav S., Silvian-Drachsler I., Tatarsky I., Lake M., and Skottner A. Comparative studies of the erythroid-potentiating effects of biosynthetic human IGF-I and II. J of Clin Endocrinol Metab 74 (1992) 447-452
14. Claustres M., Chatelain P., and Sultan C. IGF-I stimulates human erythroid colony formation in vitro. J Clin Endocrinol Metab 65 (1987) 78-82
15. Muta K., Krantz S.B., Bondurant M.C., and Wickrema A. Distinct roles of erythropoietin, IGF-I and stem cell factor in the development of erythroid progenitor cells. Journal of Clinical Investigation 94 (1994) 34-43
16. Ratajczak J., Zhang Q., Pertusini E., Wojczyck B.S., Wasik M.A., and Ratajczak M.Z. The role of insulin and IGF-I in regulating erythropoiesis. Studies in vitro under serum-free conditions-comparison to other cytokines and growth factors. Leukemia 12 (1998) 371-381
17. Corre P.N., and Axelrad A.A. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of IGF-I. Blood 78 (1991) 2823-2833
18. Correa P.N., Eskinazi D., and Axelrad A.A. Circulating erythroid progenitors in polycythemia vera are hypersensitive to IGF-I in vitro. Studies in an improved serum-free medium. Blood 83 (1994) 99-112
19. Sanders M., Sorba S., and Dainiak N. Insulin-like growth factors stimulate erythropoiesis in serum substituted umbilical cord blood cultures. Exp Hematol 21 (1993) 25-30
20. Crafts R.C., and Meineke H.A. The anemia of hypophysectomized animals. Ann NY Acad Sci 77 (1959) 501-517
21. Guler H.P., Zapf J., Scheiwiller E., and Froesch E.R. Recombinant human IGF-I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci 85 (1988) 4889-4893
22. Kurtz A., Zapf J.a.^K., Clemons G., Froesch R., and Bauer C. IGF-I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci USA 85 (1988) 7825-7829
23. Kurtz A., Matter R., Eckhardt K.U., and Zapf J. Erythropoiesis, serum erythropoietin and serum IGF-I in rats during accelerated growth. Acta Endocrinologica 122 (1990) 323-328
24. Berczi I., and Nagy E. The effect of prolactin and GH on hemolymphopoietic tissue and immune function. In: Berczi I., and Kovacs K. (Eds). Hormones and Immunity (1987), MTP press, Lancaster 144-171
25. Nagy E., and Berczi I. Pituitary dependence of bone marrow function. British J Hematology 71 (1989) 457-462
26. Jepson J.H., and McGarry E.E. Hemopoiesis in pituitary dwarfs treated with human GH and testosterone. Blood 39 (1972) 238-248
27. Tsarfaty G., Longo D.L., and Murphy W.J. Human IGF-I exerts hematopoietic growth-promoting effect after in vivo administration. Experimental Hematology 2 (1994) 1273-1277
28. Thomopoulos P., Postal-Vinay M.C., Testa U., Guyda H.J., and Posner B.I. Receptors for IGF peptides in rat reticulocytes and erythrocytes. Endocrinology 108 (1981) 1087-1090
29. Polychronakos C., Guyda H.J., and Posner B.I. Receptors for IGF on human erythrocytes. J Clin Endocrinol Metab 57 (1983) 436-438
30. Catanese V.M., Grigorescu F., King G.L., and Kahn C.R. The human erythrocyte IGF-I receptor: characterization and demonstration of ligand-stimulated autophosphorylation. J Clin Endocrinol Metab 62 (1986) 692-699
31. Philipps A.F., Persson B., Hall K., Lake M., Skottner A., Sanengen T., and Sara V.R. The effects of biosynthetic IGF-I supplementation on somatic growth, maturation and erythropoiesis on the neonatal rat. Pediatric Research 23 (1988) 298-305
32. Murphy W.J., Tsarfaty G., and Longo D.L. GH exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood 80 (1992) 1443-1447
33. Liu J.P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding IGF-I and type I IGF receptor. Cell 75 (1993) 59-72
34. Woods K.A., Camachin-Huebuer C., Savage M.O., and Clark A.J. Intra-uterine growth retardation, postnatal growth failure, association with deletion of IGF-I gene. N E J Med 335 (1996) 1363-1367
35. Rapaport R., Oleske J., Ahdieh H., Soloman S., Delfaus C., and Denny T. Suppression of immune function in growth hormone deficient children during treatment with human growth hormone. J Pediatrics 109 (1986) 434-439
36. Rapaport R., Oleske J., Ahdieh H., Skuza K., Holland B.K., Passannte M.R., and Denny T. Effect of human GH on immune function: in vitro studies on cells of normal and growth hormone deficient children. Life Science 41 (1987) 2319-2324
37. Rapaport R., and Oleske J. Effect of GH therapy on immune function. J Pediatrics 110 (1987) 663-664
38. Rapaport R., Petersen B., Skuza K.A., Heim M., and Goldstein S. Immune function during treatment of GH deficient children with biosynthetic human GH. Clin Pediatrics 30 (1991) 22-27
39. Rapaport R., and Moghaddas R. GH therapy and immune function. In: Berczi I., and Gorczynski R. (Eds). Neuroimmune biology Vol 1: New foundation of biology (2001), Elsevier Science, Amsterdam 403-408
40. Kotzman H., Riedl M., Clodi M., Barnas U., Kaider A., Hocker P., and Luger A. The influence of GH substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with GH deficiency 26 (1996) 1175-1181
41. Christ E.R., Cummings M.H., Westwood N.B., et al. The importance of GH in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with GH deficiency. J Clin Endocrinol Metab 82 (1997) 2985-2990
42. Ten Have S.M.T.H., Van Der lely A.J., and Lamberts S.W.J. Increase in Hb concentration in GH-deficient adults during human recombinant GH replacement therapy. Clinical Endocrinology 47 (1997) 565-570
43. Koc E., Bideci A., Cinaz P., Unlu M., Atalay Y., and Turkyilmaz C. IGF-I and IGF-BP3 in relation to Hemoglobin concentration in healthy term infants. Journal of Pediatric Endocrinol Metab 10 (1997) 609-613
44. Merchav S., Graif Z., and Skottner A. In vitro response of erythroid progenitors from children with thalassemia major to recombinat IGF-I and human GH. Clin Endocrinol 39 (1993) 207-211
45. Low L.C., Kwan E.Y., Lim Y.J., Lee A.C., Tam C.F., and Lam K.S. GH treatment of short chinese children with beta-thalassemia major without GH deficiency. Clin Endocrinol 42 (1995) 359-363
46. Golde D.W., Bersch N., Kaplan S.A., Rimoin D.L., and Li C.H. Peripheral unresponsiveness to human GH in Laron syndrome. N E J Med 303 (1980) 1156-1159
47. Anttila R., Koistinen R., Seppala M., Koistinen H., and Siimes M.A. IGF-I and IGF-BP3 as determinants of blood Hb concentration in healthy subjects. Pediatric Research 36 (1994) 745-748
48. Vihervuori E., Virtanen M., Koistinen R., Seppala M., and Siimes M.A. Hb level is linked to GH-dependent proteins in short children. Blood 87 (1996) 2075-2081
49. Shimon I., and Shpilberg O. The insulin like growth factor system in regulation of normal and malignant hematopoiesis. Leukemia Research 19 (1995) 233-240
50. Barak Y., Zadik Z., Haron Y., and Hahn T. Enhanced response to human circulating erythroid progenitor cells to human GH and IGF-I in children with insufficient GH secretion. Pediatric Research 32 3 (1992) 282-284
51. Miyagawa S., Kobayashi M., Konishi N., Sato T., and Ueda K. Insulin and IGF-I support the proliferation of erythroid progenitor cells in bone marrow through sharing of receptor. Br J Hematology 109 (2000) 555-562
52. Valerio G., Di Maio S., Salerno M., Argensiano A., Badolato R., and Tenore A. Association of RBC indices in GH treated children. Hormone Research 47 (1997) 62-66
53. Ratajczak M.Z., Kuczynski W.I., Onodera K., Moore J., Ratajczak J., Kregenow D.A., DeRiel K., and Gewirtz A.M. A reappraisal of the role of IGF-I in the regulation of Human hematopoiesis. J Clin Invest 94 (1994) 320-327
54. Rapaport R., Davidow A.L., and Eisenstein D. IGF-I and Hemoglobin in children with GH deficiency during treatment with Human GH. 2000 The Endocrine society, 82nd annual meeting, abstract (1983)
55. Morrison I., Eccles M.R., and Reeve A.E. Imprinting of IGF-II is modulated during hematopoiesis. Blood 96 9 (2000) 3023-3027
56. Fang S., Steinmetz R., Walker King D., Zeng P., Vogelmeid C., Cooper S., Hangcoc G., Bronx meyer H.E., and Pescovitz O.H. Development of transgenic mouse that overexpress a novel product of GH related hormone gene. Endocrinology 141 4 (2000) 1377-1383